M&T Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
M&T Bank's BMY Position: Q2 2026 in Review
M&T Bank reduced its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, selling an estimated $942K and leaving 759,648 shares worth $43.8M. The position accounts for 0.13% of the portfolio, ranked #133.
M&T Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $120M in Q2 2015. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- M&T Bank held 759,648 shares of Bristol-Myers Squibb worth $43.8M as of Q2 2026.
- M&T Bank sold 16,413 Bristol-Myers Squibb shares in Q2 2026, an estimated $942K.
- Bristol-Myers Squibb made up 0.13% of M&T Bank's portfolio in Q2 2026, its #133 holding.
- M&T Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- M&T Bank's Bristol-Myers Squibb position peaked at $120M in Q2 2015.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.